drugset / Trial / NCT06099184
Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)
RandomizedParallel-groupSingle-blindTreatment
Summary
A prospective, randomized, single-masked study evaluating the ocular efficacy and safety of two doses of the EYP-1901 intravitreal insert compared to aflibercept
Timeline
- Start
- 2024-01-15
- Primary completion
- 2024-10-24
- Completion
- 2024-10-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aflibercept | Protein / enzyme biologic | 2 mg | Intravitreal |
| Subject | CM082 | Unknown | 1343 ug | Intravitreal |
| Subject | CM082 | Unknown | 2686 ug | Intravitreal |